Quantifying proximity, confinement, and interventions in disease outbreaks: a decision support framework for air-transported pathogens by Bond, Tami C et al.
Quantifying Proximity, Confinement, and Interventions in Disease
Outbreaks: A Decision Support Framework for Air-Transported
Pathogens
Tami C. Bond,* Angela Bosco-Lauth, Delphine K. Farmer, Paul W. Francisco, Jeffrey R. Pierce,
Kristen M. Fedak, Jay M. Ham, Shantanu H. Jathar, and Sue VandeWoude
Cite This: https://dx.doi.org/10.1021/acs.est.0c07721 Read Online
ACCESS Metrics & More Article Recommendations *sı Supporting Information
ABSTRACT: The inability to communicate how infectious
diseases are transmitted in human environments has triggered
avoidance of interactions during the COVID-19 pandemic. We
define a metric, Effective ReBreathed Volume (ERBV), that
encapsulates how infectious pathogens, including SARS-CoV-2,
transport in air. ERBV separates environmental transport from
other factors in the chain of infection, allowing quantitative
comparisons among situations. Particle size affects transport,
removal onto surfaces, and elimination by mitigation measures, so
ERBV is presented for a range of exhaled particle diameters: 1, 10,
and 100 μm. Pathogen transport depends on both proximity and
confinement. If interpersonal distancing of 2 m is maintained, then
confinement, not proximity, dominates rebreathing after 10−15
min in enclosed spaces for all but 100 μm particles. We analyze strategies to reduce this confinement effect. Ventilation and filtration
reduce person-to-person transport of 1 μm particles (ERBV1) by 13−85% in residential and office situations. Deposition to surfaces
competes with intentional removal for 10 and 100 μm particles, so the same interventions reduce ERBV10 by only 3−50%, and
ERBV100 is unaffected. Prior knowledge of size-dependent ERBV would help identify transmission modes and effective interventions.
This framework supports mitigation decisions in emerging situations, even before other infectious parameters are known.
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■ INTRODUCTION
The spread of the SARS-CoV-2 virus has created a public
health crisis and widespread economic disruption.1 Key factors
in the extent of this crisis are (i) the severity of the disease,
COVID-19, so avoidance is preferred over illness; (ii)
transmission by asymptomatic or presymptomatic individu-
als;2,3 and (iii) the novelty of the disease, so that decisions
must occur before scientific investigations are definitive.
Although this situation is unprecedented in the past century,
pandemics have occurred throughout human history. An event
like COVID-19 was predicted before its onset4 and is likely to
occur again with different infection dynamics.5,6
Figure 1 illustrates the chain of infection,7 modified to
emphasize the role of person-to-person interactions. After a
pathogen has entered the human population, escape from the
human reservoir depends on the prevalence and characteristics
of disease carriers or emitters. On the receiving end, the
likelihood of infection is determined by the host’s susceptibility
and the dose received. The mode is the method of travel
between the pathogen’s release and the host. The pathogen’s
survival characteristics limit viable modes, but the environment
modulates the transferred dose. This environment includes the
social system that compels intersection between individuals
and the physical environment through which the pathogen
travels. Uncertainty about physical transmission has led to
suspicion about the interactions that underpin the economy.
The ability to quantify exposure risks in social interactions
more quickly and rigorously would aid decision-making in
current and future outbreak situations.
Describing the chain of infection requires expertise in
epidemiology, infectious disease, sociology and data science,
engineered and natural environments, virology, immunology,
and public health. Each field has burgeoned since Riley’s
pioneering work8 combined carrier and environmental
characteristics into a single equation, yet few metrics distill
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the essential elements of the chain for use in collaboration. The
separation of emitter, environment, and host characteristics
would allow experts to collaborate more rapidly during an
emerging situation. This paper describes a metric to quantify
pathogen transport and uses it to compare transmission
environments and mitigation measures.
A particular challenge in any emerging situation is
uncertainty in the mode of transmission. Public health
guidance9 uses the terms “droplet” and “short-range” for
large expiratory particles that transport through air but are lost
quickly by falling. A second mode, via small particles that tend
to follow airstreams, is termed “airborne”, “aerosol”, or “long-
range”. A third mode is called “indirect” when pathogens are
transferred through intermediate, contaminated objects,
including human skin.10 Dominant modes of transmission
are hotly debated for COVID-1911,12 and other respiratory
infections.13 Despite the differences in terminology, the
dynamics of transport through air govern the first two modes
and play a role in the third.
The approach we present does not champion any particular
mode but instead acknowledges the importance of particle size
in every step of the chain of infection. Particle size and viral
content are influenced by where particles originate within the
respiratory tract;14 size affects the depth of penetration into the
recipient’s lungs and susceptibility.15 Size dominates particle
fate; large particles do not remain suspended as long and are
easier to remove because of the relative influences of gravity,
drag force, and attachment to surfaces or deposition.
■ METHODS
Quantifying Person-to-Person Transport. A metric to
characterize and communicate person-to-person transport
should be understandable by individuals outside the field,
able to encapsulate complex situations and incorporate
evolving knowledge, generalizable to archetypal building
situations, and germane to decision making by comparing
alternative interactions. It should not be confounded by
differences in human emitters or recipients, which are
independent of transport.
We choose rebreathed volume (RBV) as a basic metric for
this purpose. RBV is the total volume of air exhaled by one
person and subsequently inhaled by another. RBV is
proportional to the total dose that an individual receives; we
also use the rate of rebreathing to compare different
interactions of equal lengths. If a recipient were inhaling
directly from the mouth of an emitter, the rebreathing rate
would be the human breathing rate of 8 L min−1,16 and over 10
min, RBV would be 80 L. RBV can be calculated from simple
models, computational fluid dynamic models, and tracer
measurements in both indoor and outdoor situations (SI
S.1−S.4).
RBV is similar to other metrics and can be calculated from
them (SI S.9), including the Wells−Riley equation for
probability of infection,8 inhalation intake fraction,16 or
rebreathed fraction.17 However, RBV quantifies the role of
the transmission environment, separate from individual
characteristics of carriers and hosts. It does not require a
quantum generation rate as does the Wells−Riley equation and
is independent of the number of participants, unlike intake
fraction and rebreathed fraction. RBV quantifies person-to-
person sharing of breath during standard conditions and
activities. To determine risk of infection for specific activities,
occupancies, and diseases, crowding effects and adjustments to
breathing rates need to be applied (SI S.9). Some analyses have
presented the entire chain of infection for SARS-CoV-2
transmission,18−20 but they have not isolated the environ-
mental component as is done here.
To communicate transport dynamics of differently sized
particles while maintaining simplicity, we define ef fective
rebreathed volume (ERBV) as the exhaled volume that contains
the same number of particles as the air inhaled by the recipient.
If a recipient received 80 L of RBV from an emitter, and 90%
of particles with diameter X were lost by settling, then ERBVX
would be 8 L (80 L multiplied by 10% remaining). This
physics-based treatment allows objective comparison of
transmission modes by accounting for the main difference in
particle transport: size-dependent loss.
We choose decadally spaced sizes that cover a biologically
relevant range: 1, 10, and 100 μm diameter (ERBV1, ERBV10,
and ERBV100, respectively). Sizes of expiratory particles range
from 0.01 to 1000 μm,21−23 although the largest particles are
rarely measured. The 1000 μm particles are excluded because
they would travel less than 1 m due to their rapid fall speeds.
Particles the size of a bare virion (0.1−0.2 μm) probably do
not exist in free air, but in any case they would travel like 1 μm
particles because they have similar indoor deposition loss rates
(SI). Large expiratory droplets evaporate within a few
seconds,24,25 and a 100 μm droplet would become about 20
μm after losing 99% water content.26 The transport we present
assumes that this transformation has already occurred.
Model Selection. Exhaled volume is treated as a conserved
tracer with losses that depend on particle size. All equations for
transport of a contaminant in fluids can be used to predict
exhaled volume per volume of air. A challenge in developing
comparative transport metrics has been the limited literature
describing the travel of contaminants within a few meters of a
source or emitter, which we call “source-proximate transport.”
A contribution of this work is therefore a review of modeling
approaches to estimate rebreathed volume. The models chosen
Figure 1. Chain of infection for a disease whose spread depends on human interactions. Figure credit: Mj Riches.
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are summarized here, and equations and further justification
appear in the Supporting Information.
The models ultimately chosen are simple, yet they capture
the major factors that affect contaminant transport: distance
from emitter, accumulation in confined spaces, dispersion rate,
and the influence of other loss rates including mitigation
measures. The simulations can therefore be used to compare
expected values of rebreathing, even between very different
environments such as within and outside of buildings. The
chosen models do not rely on specialized inputs such as surface
temperatures or roughness or detailed interior geometries.
Such requirements would preclude general recommendations
and comparisons among environments.
For outdoor interactions, we used a steady-state Gaussian
plume equation27 over a range of atmospheric stability
conditions. The Gaussian plume is typically not used to
describe transport over short distances, because contaminants
travel in irregular packets. However, average concentration
values do follow the expected shape, even 2 m from the
emitter,28,29 and the distribution of concentration due to
sporadic transport on short time scales can be described
probabilistically.30 We therefore combined the Gaussian-
predicted concentrations with an intermittency enhancement30
as a worst case. SI S.2 provides more details.
For most indoor interactions, we used a well-mixed zone
model, which assumes that concentrations are the same
throughout each zone. The model was cast in a matrix form31
to simulate multiple zones, including connections through
central air systems (SI S.3). Few reports quantify deviations
from the well-mixed zone assumption other than proximity
effects. Variations in indoor cooking smoke concentrations can
be about a factor of 2 from lowest to highest.32 Stochastic
variations in infection rate from interzonal transport were
simulated as about 40%.31 No evidence suggests that expected
values from well-mixed simulations are biased. Stochastic
variations do not invalidate comparisons between expected
values of rebreathed volume, which are averaged across the
entire environment. If those variations are not observable or
predictable, they cannot be manipulated to reduce risk, either.
The well-mixed zone assumption does not represent displace-
ment ventilation, but deliberate use of this strategy is not
widespread. The assumption also ignores stagnation zones,
which are much less likely to contain respiring humans than
other parts of the room.
Elevated concentrations occur near emitters indoors. We
simulated indoor proximity effects with a point-release
model,33 modified to represent a continuous source with
dispersion parameters dependent on air-change rates (SI
S.4).34 Simulated concentrations agreed with steady-state, well-
mixed values at distances far from the emitter or when
dispersion was similar to outdoor values. We assume worst-
case rebreathing rates, when the emitter and recipient breathe
at the same level. We also interpreted the few available
measurements of indoor proximity in terms of ERBV (SI S.4)
for comparison. Indoor proximity effects have been simulated
with computational fluid dynamic models, but we did not find
quantified source or breathing rates that would allow
interpretation in terms of rebreathed volume. Computational
fluid dynamic studies often simulate particular ventilation,
furnishing, or occupancy features; they would be useful to
understanding of ERBV by including enough variation to allow
generalization.
Selection of Inputs. We identified a range of common
floor area and air exchange rates for residential and office
situations (SI S.7, S.8), selected for general interest. Residential
situations range from small apartments to moderate-sized
single-family homes; offices with similar floor areas were
chosen for comparability. We used a range of common air
exchange rates for each situation (SI S.7, S.8), based on
measurements and recommendations from the American
Society of Heating, Refrigerating and Air-Conditioning
Engineers (ASHRAE).35,36
Particle removal by deposition is the reason that ERBV
differs among particle sizes and affects effectiveness of
mechanical mitigation measures. We use the theoretical
model by K. Lai and Nazaroff37 to provide central values.
However, measured deposition is often faster than model
predictions,38 especially for particles smaller than 1 μm and in
occupied houses. Uncertainties are taken from observa-
tions39,40 as summarized in SI S.5 and Table S.2.
Mitigation Measures. Mitigation measures focus on
reducing the confinement effect indoors and included
improving filtration in central air handlers, adding stand-
alone air cleaners, staggering occupancy in office situations,
and employing exhaust fans and opening windows in
residential situations. Removal by filtration occurred at the
inlet of the central air system. When natural infiltration
dominated air exchange, we accounted for reduced effective-
ness of mechanical ventilation.41
The importance of each particle size is different for each
pathogen and is unknown in an emerging situation, so we
present fractional reductions in ERBV for all three particle
sizes. Size-dependent filter efficiencies are taken from ASHRAE
Standard 52.2-201742 with ratings as described Tables S.4 and
S.5. Mitigation by ultraviolet disinfection in central air handlers
would be comparable to filtration with similar efficiencies. Each
mitigation measure was applied to each baseline case, the
reduction percentage was calculated, and the entire range of
reduction percentages is presented.
Risk Reduction Context. Risk may not be reduced by the
same fraction as transmitted dose. Dose−response curves are
typically used to infer a change in risk, but quantitative dose−
response curves are unknown in an emerging situation and
often remain uncertain even for well-studied pathogens.
However, dose−response relationships for many viruses have
similar features. Human and animal responses typically show a
zero risk of infection below a minimum infectious dose, and
near-certainty of infection above infectious dose 95% (ID95,
also called “saturated”). If the baseline dose is below the
minimum infectious value, then mitigation measures are not
required. Conversely, if the baseline exceeds ID95, mitigation
does not effectively reduce risk without a significant reduction
in dose. Between the minimum infectious dose and ID95,
dose−response curves often have a sigmoidal shape. At the
dose that is likely to infect 50% of susceptible individuals
(ID50), infection risk rises approximately linearly with the
logarithm of dose. Mitigation measures are effective only when
applied over this responsive portion of the curve, and efficacy
depends on both the baseline risk relative to ID95 and the
range, or width, of infectious doses spanned by the sloping
portion of the infection curve.
We created two illustrative dose−response curves to
demonstrate how the baseline dose and width of the dose−
response curve affect expected risk reductions. These two
curves have identical values of ID50, but different widths; we
Environmental Science & Technology pubs.acs.org/est Article
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refer to these as “moderate” and “wide” (Figure S.5).
Watanabe et al.43 summarized studies on SARS-CoV-1, a
virus that is similar to SARS-CoV-2. They explored both
exponential and beta-Poisson distributions to fit observed risk
of infection, recommending the former because the beta-
Poisson distribution did not have a statistically better fit.
However, the exponential distribution has a fixed width, so we
used the beta-Poisson distribution. The “moderate” dose−
response curve has a width similar to the synthesized curve of
Watanabe.43 The doses associated with 5% risk and with 95%
risk differ by a factor of 100, informally called “2 logs.” For the
“wide” curve, the distance between 5% risk and 95% risk is a
factor of 3100 (“3.5 logs”), similar to estimates by Kitajima et
al.44 for H5N1. Again, we make no assumption that any
infectious disease can be represented by these dose−response
curves; we use only the curve’s shape to connect mitigation
measures might reduce risk.
■ RESULTS AND DISCUSSION
Proximity and Confinement Effects. Figure 2 compares
the rate of rebreathing during simple maximum outdoor (red,
shaded) and indoor (blue, dashed) interactions for 1, 10, and
100 μm particles. The contrast between the three particle sizes
shows the importance of separate consideration. Person-to-
person transport of pathogens is greater in close proximity,
partly because contaminants spread out (disperse) as they
travel away from an emitter, and partly because they also fall
out (deposit) during that travel. Person-to-person transport is
also greater in close conf inement, where contaminants
accumulate when they cannot escape the walls of an enclosure.
Outdoors, concentration decreases with distance from the
emitterbecause particles are carried by wind and dispersed by
air fluctuations. The proximity effect is especially attributable
to dispersion but also deposition for large particles. The
gravitational settling that differentiates particles is negligible for
1 μm and 10 μm particles, but some 100 μm particles have
fallen out after traveling 2−3 m. Public guidance in 2020
Figure 2. Instantaneous effective rebreathing rate for outdoor (red, with shaded area) and indoor (blue, dashed) interactions for particles of
diameter (A) 1 μm; (C) 10 μm; (D) 100 μm. Horizontal axes for proximity (lower) and confinement (upper) axes are not equivalent but appear
on the same figure for comparison. Note the difference in vertical axis scales. Rebreathing rates are person-to-person and would increase for more
emitters.(B) Comparison of outdoor and indoor proximity for a range of simulated indoor conditions, for 10 and 120 min after emitter entry, and
in this figure the horizontal axes are the same.
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suggests maintaining 2 m separation between individuals,
avoiding the highest concentrations. At this distance, the
outdoor rebreathing rate is less than 0.01 L min−1, and it would
be even lower if the recipient were not directly downwind
(Table 1).
Figure 2 also shows rebreathing in well-mixed, enclosed
rooms (blue dashed curves), where the confinement effect
occurs because exhaled air accumulates rather than dispersing.
Within 15 min indoors, the rebreathing rate for 1 and 10 μm
particles exceeds that of a 2 m distance outdoors, with more
rebreathing in small rooms. An individual who is unwilling to
stand within 2 m of a potential emitter outdoors may
unwittingly accept the same or greater risk by remaining in a
moderate-sized room for 15 min, even at distances greater than
2 m. This is true regardless of variability or uncertainty in
model inputs.
Figure 2 demonstrates sensitivities to different assumptions.
The rate of rebreathing depends on length of accumulation
(upper x-axis throughout Figure 2) and room size (thick blue
lines in Figure 2a,c,d). Particles of 100-μm deposit rapidly and
do not accrue, so indoor rebreathing is low, consistent with
particles classically termed “droplets” (Figure 2d). Ventilation
rates reduce rebreathing noticeably for interaction times above
about 30 min, as shown for the 1 μm particles in Figure 2a. For
these particles, uncertainties due to deposition are relatively
small (not shown). Particles of 10 μm diameter deposit more
quickly than smaller particles, so indoor ERBV10 is lower than
ERBV1 (Figure 2c). Nevertheless, rebreathing of 10 μm
particles is still important in confined spaces. ERBV10 is
affected by ventilation (not shown) but is also greatly affected
by uncertain deposition rates.
Contaminants disperse quickly indoors,45 but both prox-
imity and confinement effects occur in enclosed spaces. Figure
2b shows indoor rebreathing rates of 1 μm particles simulated
with a point-release model33,34 for 10 and 120 min after
emitter entry. Minimum, median, and maximum values for a
range of dispersion rates, emitter positions, and room sizes are
presented. The maximum curve is discontinuous because the
Table 1. Person-to-Person Effective Rebreathed Volume for
1 μm Particles (ERBV1) in Common Interactions
effective rebreathed volume (L)





0.02−0.14 0.1−0.58 0.58−0.98 a−c
same, 2 m distance 0.005−0.04 0.02−0.14 0.14−0.24 a−c
45° from wind dir,
1 m distance
<0.0004 <0.001 <0.006 a−c
indoors
small room, 1 m
distance
0.17−0.28 2.7−3.9 12.2−20 d−f
same, 2 m distance 0.063−0.071 1.7−2.1 9.1−14 d−f
same, well mixed 0.075−0.079 1.0−1.2 8.9−14 e−g
communal office,
well mixed
0.011−0.012 0.15−0.17 1.2−1.9 f−h
aERBV is proportional to interaction time, because there is no
confinement effect. bPlume model with wind of 2.5 m s−1; urban
topography, range of weather conditions. cIntermittency increase is
not included, because fluctuations average out after 15−20 min.
dFrom indoor point-release model, 0.3−0.8 ac h−1. eFloor area 36 m2,
height 2.5 m2, size of small conference room or living room.
fAssuming emitter and recipient enter simultaneously. gFrom well-
mixed zone model, 0.3−0.8 ac h−1. hFloor area 200 m2, height 3 m2.
Figure 3. Person-to-person ERBV for 4 h interactions in (A) residential and (B) office settings, along with reductions due to mitigation measures.
Horizontal shading in the individual rectangles shows realistic variability in environment and facilities, such as different floor areas (SI). In
residential settings, “Central” means operating the central air handlers, common in the United States, continuously (100%) or with a 25% runtime.
Most of these systems filter air but do not provide air from outdoors; ventilation is provided with bath and kitchen exhaust fans. The situation
differs in office buildings, where continuously operating central air handlers supply cleaned outdoor air as well as filtering recirculated air. “Air
cleaner” refers to portable, stand-alone air cleaners with high-efficiency filtration. SI contains additional details, along with figures for 15 min and 1
h interactions.
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greatest rebreathing occurs in small rooms of 4 m width, and
those simulation results disappear from the summary curve at
more than 2 m. Also included are values interpreted from
chamber measurements,46,47 which fall within the simulation
range.
After 10 min of residence time, indoor and outdoor
proximity effects are similar. An elevated proximity effect, as
well as a confinement effect throughout the room, occurs after
2 h. These simulations are simplified; indoor dispersion rates
depend on the intensity of turbulence in the room, which in
turn is affected by environmental conditions, surface proper-
ties, sources of thermal energy, and even the buoyancy around
a human body.47 Regardless of these variations, all simulations
demonstrate a sharp decrease in the proximity effect indoors
and outdoors within 1−1.5 m. Momentum from breathing,
coughing, or sneezing affects travel of particles immediately
after emission, and that effect is not modeled here. Except in
extreme cases such as violent sneezes, that initial momentum
governs transport only within the first 1.5 m.24 Thus, the 2 m
distancing guideline addresses much of the proximity effect,
whether it is caused by dispersion or momentum. The purpose
of this work is not to quantify the proximity effect in all
situations. Rather, we confirm that it exists both outdoors and
indoors, that it is greatly reduced at a distance of 2 m, and that
the confinement effect is frequently greater than the proximity
effect occurring at 2 m, regardless of uncertainties in either
one.
Total ERBV is obtained by summing over the recipient’s
entire residence time. Table 1 summarizes ERBV1 over 15 min,
1 h, and 4 h interactions, which represent a brief face-to-face
commercial transaction, a business meeting, and a half-day
working session, respectively. The definition of “close contact”
from the Centers for Disease Control and Prevention is “within
6 feet for at least 15 min”, corresponding to a minimum ERBV
of about 0.07 L for any particle size. Regardless of whether the
participants are farther apart than 2 m distance, confinement in
the two smaller rooms in Figure 2 causes ERBV to exceed the
“close-contact” value after about 10−15 min, for both 1 and 10
μm particles.
Effect of Mitigation Measures. Rebreathing can be
lessened when the participants remain at a distance to reduce
proximity effects. Other solutions are needed to reduce the
confinement effect, and those are explored here. Figure 3
summarizes ERBV for a 4 h stay in residential (Figure 3b) and
office (Figure 3b) settings.
The upper portion of the figure shows how size-dependent
losses affect rebreathing: ERBV1 is 2 orders of magnitude
greater than ERBV100. This difference does not imply that 1
μm particles have the highest infectivity. If exhaled air contains
few or no pathogens of this size, then the efficient transport
indicated by high ERBV1 is unimportant. The high value does
indicate that even a small release of pathogens in 1 μm
particles would be easily transmitted to a recipient. Likewise,
the lower value of ERBV10 does not indicate unimportance.
Particles of 10 μm diameter might be transmitted less
efficiently, but this size range could still contain most of the
infective particles.
The lower part of each figure shows rebreathed volume
reductions by ventilation, filtration, and occupancy or zoning
measures. The lowest rows show the effect of cloth or surgical
face coverings for comparison, with uncertainty in efficiency
shown as a range of shading. For mechanical measures
(ventilation and filtration), achievable reductions depend on
the fraction of time operating, flow rate compared to room
volume, and filtration efficiency. Many common filters remove
particles of 10 μm diameter and larger, with efficiencies
improving at higher filter ratings; lower rated filters do not
remove 1 μm particles.
ERBV100 is not noticeably reduced with any ventilation or
filtration strategy because these large particles are lost by
deposition more quickly than they can be removed
mechanically. Offsetting occupancy, wearing face coverings,
and separating occupants between roomseven with doors
opendoes reduce ERBV100.
ERBV1 can be reduced with many ventilation and filtration
strategies. Ventilation should bring clean air into the
environment, while filtration recirculates and cleans air.
Reductions in ERBV10 by mechanical measures are inter-
mediate between ERBV1 and ERBV100. Some effective
mitigation measures would be neglected by assuming that 1
and 10 μm particles are unresponsive to mechanical means like
large, 100 μm droplets. In residences (Figure 3a), kitchen
range hoods reduce ERBV1 by 30−40% and bath fans, with
about half the flow, by only 15−30%. Opening windows
reduces ERBV1 by 25−65%, with the wide range caused by
differing response to opening size and position. When central-
air units operate continuously with medium- or high-rated
filters, reductions are 15−55%; lower operating time decreases
those benefits. Separating individuals between rooms gives
moderate reductions, while closing doors between them is the
best protection as long as central air handlers are not
operating. Offices have more closely controlled ventilation
than do homes, and a narrower range of ERBV and mitigation
effectiveness. Increasing the amount of outdoor air supplied
and improving the filter both reduce ERBV1, while ERBV10
reductions are lower because the baseline already includes
some removal of 10-μm particles. Staggered occupancy, in
which one person enters after another leaves,48 reduces ERBV1
similar to medium-rated filtration. Vacancy periods increase
the reduction. These findings depend on the assumption of
well-mixed spaces and do not include additional management
strategies such as personalized or displacement ventilation,
which could be investigated further by comparing ERBV
values.49
Deposition loss rates are a key reason that 1 and 10 μm
particles differ in baseline ERBV and also explain differences in
the ventilation effectiveness shown in Figure 3. Deposition loss
rates for 10 μm particles are similar to or greater than air
exchange rates, so total removal is less influenced by
intentional ventilation changes. In comparison, removal of 1
μm particles is dominated by air exchange and easily altered by
ventilation. A good understanding of indoor deposition rates
therefore underlies quantification of ventilation effectiveness,
but these loss rates are infrequently measured, and measured
deposition is usually faster than theoretical predictions.50
Further discussion of deposition and its influence on
ventilation effectiveness is given in SI S.10.
The difference between ERBV1, ERBV10, and ERBV100 offers
the possibility to determine particle sizes most likely involved
in transmission through retrospective analysis. For example,
staggered occupancy (one 4 h shift following another) reduces
ERBV1 by about 60% but ERBV10 by over 99%. In an emerging
disease outbreak, the infectious nature of 1 μm versus 10 μm
particles might be elucidated by seeking situations in which an
index patient infected others in the same shift and did or did
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not infect others in the next shift. A similar epidemiological
exploitation has been proposed previously.51
Mitigation in Meaningful Ranges. Thus far, we have
presented ERBV in baseline situations and identified
percentage reductions possible with mitigation measures. We
now discuss the situations under which those fractional
reductions would actually reduce risk.
Figure 4 illustrates risk reductions beginning with four
baseline risks and two dose−response curve widths, where the
reduction in dose (x-axis) corresponds to the change in ERBV.
The upper portion of Figure 4 shows the reductions possible
from the measures in Figure 3. Risk via ERBV1 is reduced by
many mechanical measures in residential situations and most
measures in office situations. Except for occupancy strategies,
many measures do not have a large effect on risk via ERBV10 in
office settings. Ventilation strategies do reduce risk via ERBV10
in residential settings. When the original risk is very high
(95%) and the dose−response curve is wide, the large
reductions needed to achieve meaningful reductions are not
possible with any mechanical measures.
The dose−response relationship is not known in an
emerging disease outbreak. Observations of rebreathed volume
can serve as a proxy for dose during early decisions about
mitigation. When ERBV is comparable to another situation in
which infection has spread widely, mitigation measures that
give at least order-of-magnitude reduction should be
implemented. Identifying ERBV values when infection does
and does not occur could suggest the width of the curve, even
if uncertainty in ERBV were a factor of 3 (about 100.5).
Practical Uses of Effective Rebreathed Volume. By
acknowledging that particle size is the cause of differences in
transport, ERBV avoids the legacy “droplet” versus “aerosol”
dichotomy. We propose that the following steps would have
lessened some of the economic impact associated with the
COVID-19 pandemic:
(1) Building designers would have determined ERBV1,
ERBV10, and ERBV100 at the time of commissioning,
providing values that quantified both normal and
transmission-minimizing circumstances.
(2) Epidemiological studies would immediately exploit known
differences in ERBV1, ERBV10, and ERBV100 to identify
particle sizes associated with infection as soon as
outbreaks emerged. They might also identify ERBV
associated with saturation and approximate widths of
dose−response curves. Effective interventions could
then be better targeted.
(3) Facility managers could evaluate venues, for example,
comparing ERBV for different rooms or for indoor
versus outdoor locations. As information emerged, they
would be guided in their determination with values of
ERBV that were known to be saturated and safe.
(4) Public health messaging would include ERBV so that each
individual could make informed choices about inter-
actions based on relative and overall risk acceptance.
Figure 4. Possible changes in risk associated with reductions in ERBV. Percentage reductions in ERBV (upper x-axis) are the same as percentage
reductions in dose (lower x-axis) and can thus be associated with risk remaining after a specific dose reduction. Baseline risk and dose−response
curve width are not known, and uncertainty in risk reduction is demonstrated using illustrative curves with “moderate” and “wide” shapes. Labels on
“Office” and “Residential” measures correspond to the specific measures grouped in Figure 3, and ranges for each category cover all measures and
situations. ERBV100 is not shown because most of the mitigation measures have no effect.
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These types of evaluation have all been conducted casually
during the COVID-19 pandemic. We developed the size-
dependent ERBV metric to provide rigor to such informal
evaluations, to isolate the environmental component of the
chain of infection, to identify limiting uncertainties like indoor
deposition rates, and to provide a framework that supports
rapid response in future outbreaks.
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